Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.605
+0.024 (4.15%)
At close: Nov 21, 2024, 4:00 PM
0.591
-0.014 (-2.38%)
After-hours: Nov 21, 2024, 4:07 PM EST
Elevation Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 36 | 23 | 22 | 140 | - | - |
| Market Cap Growth | 26.27% | 2.97% | -84.16% | - | - | - |
| Enterprise Value | -38 | -42 | -56 | -16 | - | - |
| Last Close Price | 0.58 | 0.54 | 0.95 | 6.02 | - | - |
| PB Ratio | 0.50 | 0.42 | 0.45 | 0.99 | - | - |
| P/TBV Ratio | 0.51 | 0.42 | 0.45 | 0.99 | - | - |
| Debt / Equity Ratio | 0.45 | 0.55 | 0.60 | - | - | - |
| Quick Ratio | 17.39 | 20.05 | 5.75 | 16.64 | 11.70 | 2.91 |
| Current Ratio | 17.77 | 21.22 | 5.93 | 17.00 | 11.91 | 3.21 |
| Return on Equity (ROE) | -63.67% | -88.03% | -100.23% | -29.83% | -45.78% | - |
| Return on Assets (ROA) | -25.46% | -27.52% | -48.51% | -17.39% | -26.07% | - |
| Return on Capital (ROIC) | -27.24% | -30.86% | -53.93% | -18.65% | -28.63% | - |
| Earnings Yield | -122.10% | -200.66% | -429.82% | -22.94% | - | - |
| FCF Yield | -111.61% | -246.66% | -386.83% | -21.60% | - | - |
| Buyback Yield / Dilution | -81.44% | -46.46% | -91.77% | -1432.24% | -6.43% | - |
| Total Shareholder Return | -81.44% | -46.46% | -91.77% | -1432.24% | -6.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.